Reason: Brachytherapy planning History: Brachytherapy planning. PELVIS:UTERUS, ADNEXA: Interval placement of tandem and ovoid apparatus. Cervical mass compatible with patient's history cervical cancer has significantly decreased in size with no detectable disease on T2 sequences. Small focus of enhancement measures 2.5 x 1.7 cm (series 1101 image 279), previously 2.9 x 2 cm and may represent inflammatory reaction or small residual disease. The mass remains in close proximity to the rectum. Previously noted loss of fat plane between the mass and the left pelvic side wall is again appreciated. Uterine fibroids and nabothian cysts have not significantly changed.BLADDER: No significant abnormality noted.LYMPH NODES: Reference right pelvic sidewall lymph node measures 1.5 x 0.6 cm (series 801 image 83), previously 1.6 x 0.8 cm. Previously referenced left pelvic sidewall rounded lymph node has also slightly decreased in size (series 801 image 34).BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: Partially visualized large left renal cyst extending into the pelvis is again noted.
Cervical mass and bilateral pelvic sidewall lymphadenopathy have decreased in size compared to prior.